| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | ciclesonide (Alvesco®) |
| Formulation | 80 micrograms and 160 micrograms inhaler |
| Reference number | 86 |
| Indication | Prophylactic treatment of persisitent asthma in adults, adolescents and children (aged 18 years and over) |
| Company | Nycomed UK Ltd |
| BNF chapter | Respiratory system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 15/03/2005 |